The Venture Codex Logo

The Venture Codex

Eisai

4-6-10 Koishikawa, Tokyo, Bunkyo-ku, 112-8088, Japan

Overview

Integrated pharmaceutical company specializing in oncology and neurology.

Founded

1941

Deals · 12mo

1

Links

WebsiteLinkedInX (Twitter)

Stage focus

Seed
Series A
Series C

Geographic focus

Canada
China
Finland
Singapore
...

Sector focus

Biotechnology
Health Care
Pharmaceutical

Investment portfolio

11rounds
NAMEDATESIZE
Beren Therapeutics
Jun 2026Participated
$245 MOther Equity
Seed Therapeutics
Aug 2024Led
$24 MSeries A
C2N Diagnostics
Mar 2024Led
$15 MOther Equity
Casma Therapeutics
Nov 2022Participated
$46 MSeries C
Ractigen Therapeutics
Jan 2022Participated
$30 MSeries A
Neuroglee Therapeutics
Sep 2021Participated
$10 MSeries A
Oura
May 2021Participated
$100 MSeries C
Neuroglee Therapeutics
Dec 2020Led
$2 MSeed
Unlearn
Nov 2020Participated
$3 MSeries A
Darmiyan
Apr 2020Led
$6 MSeed
Numab
Mar 2020Participated
$24 MSeries B
Beren Therapeutics
Jun 2026Participated
$245 MOther Equity
Seed Therapeutics
Aug 2024Led
$24 MSeries A
C2N Diagnostics
Mar 2024Led
$15 MOther Equity
Casma Therapeutics
Nov 2022Participated
$46 MSeries C
Ractigen Therapeutics
Jan 2022Participated
$30 MSeries A
Neuroglee Therapeutics
Sep 2021Participated
$10 MSeries A
Oura
May 2021Participated
$100 MSeries C
Neuroglee Therapeutics
Dec 2020Led
$2 MSeed
Unlearn
Nov 2020Participated
$3 MSeries A
Darmiyan
Apr 2020Led
$6 MSeed
Numab
Mar 2020Participated
$24 MSeries B
11
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Eisai: 11 funding rounds are recorded in the selected participation categories.All available history.
Eisai: 11 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed20
Series A13
Series B01
Series C+02
Other Equity11

Monthly Deal Activity

Eisai: 11 deals are recorded across 80 months.All available history.
Eisai: 11 deals are recorded across 80 months. All available history
MonthDeals
Mar '201
Apr '201
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '201
Dec '201
Jan '210
Feb '210
Mar '210
Apr '210
May '211
Jun '210
Jul '210
Aug '210
Sep '211
Oct '210
Nov '210
Dec '210
Jan '221
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Eisai: Health & Life Sciences is the largest displayed sector by deal count (10 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Eisai: Health & Life Sciences is the largest displayed sector by deal count (10 deals). All available history
SectorDeals
Health & Life Sciences10
Hardware & Robotics1
Education & Workforce1
Enterprise Software1
AI & Machine Learning1
Developer Tools1

Deal Size Distribution

Eisai: 11 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Eisai: 11 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M2
$5M-$10M1
$10M-$25M4
$25M-$50M2
$50M-$100M0
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Eisai: United States has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 5 of 5 regions; European countries are grouped as Europe.

Eisai: United States has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
United States5
Singapore2
Europe2
Canada1
China1
Eisai: 20 co-investors are shown, with Alumni Ventures sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Eisai: 20 co-investors are shown, with Alumni Ventures sharing 1 recorded deals. All available history
Co-investorShared deals
Alumni Ventures1
Amgen Ventures1
Astellas Venture Management1
CSSD Capital1
Dell Family Office1
EDBI1
Elysian Park Ventures1
Epic Ventures1
Euclidean Capital1
Eventide Asset Management1
Forerunner Ventures1
Founders Fund1
Guotou Chuangye1
Hercules Capital1
IT-Farm1
JAZZ Venture Partners1
JIC Venture Growth Investments1
LC Ventures1
Lifeline Ventures1
Metaplanet1

Investment Strategy

Eisai: Led accounts for 36% and participating for 64% of round participation.All available history.
Eisai: Led accounts for 36% and participating for 64% of round participation. All available history
CategoryDeals (count)Share (%)
Led436%
Participating764%
Eisai: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Eisai: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead4100%
Co-led00%

Team

Chad Swanson

Executive Director, Neurology Business Group; Clinical Research

Eran Nadav

Business Development Director

Haruo Naito

CEO

Stewart Geary

Deputy Director

Wil Foster

Director Regulatory Affairs

Yasushi Okada

COO

Yuji Matsue

Chairman & CEO